Astragalus polysaccharide significantly alleviates colonic damage in ulcerative colitis by inhibiting pro-inflammatory factors (TNF-α, IL-6, IL-1β) and oxidative stress products (MDA) and restoring the activity of antioxidant enzymes (SOD) (Hu et al., 2022). The gene discussed is IL6; the disease is ulcerative colitis.